Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Beta-blockers in patients with intradialytic hypertension: are they potent anti-hypertensives?

    Marieta Theodorakopoulou, Fotini Iatridi in International Urology and Nephrology (2024)

  2. Article

    Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework

    Carmine Zoccali, Francesca Mallamaci, Jean-Michel Halimi in Nature Reviews Nephrology (2024)

  3. No Access

    Article

    Chronic cardiovascular–kidney disorder: a new conceptual framework

    The current nomenclature for cardiorenal syndrome is problematic owing to its chronological approach and the systemic nature of some of the subtypes. We suggest adoption of a new concept, chronic cardiovascula...

    Carmine Zoccali, Francesca Mallamaci, Jean-Michel Halimi in Nature Reviews Nephrology (2024)

  4. No Access

    Article

    Accuracy of 24 h ambulatory blood pressure recordings for diagnosing high 44 h blood pressure in hemodialysis: a diagnostic test study

    Hypertension is highly prevalent in hemodialysis patients. Ambulatory-BP-monitoring(ABPM) during the 44 h interdialytic interval is recommended for hypertension diagnosis and management in these subjects. This...

    Marieta Theodorakopoulou, Areti Georgiou, Fotini Iatridi in Hypertension Research (2024)

  5. No Access

    Article

    Diagnosis of cardiovascular disease in patients with chronic kidney disease

    Patients with chronic kidney disease (CKD) are at high risk of cardiovascular disease (CVD) and cardiovascular death. Identifying and monitoring cardiovascular complications and hypertension is important for m...

    Carmine Zoccali, Patrick B. Mark, Pantelis Sarafidis in Nature Reviews Nephrology (2023)

  6. No Access

    Article

    Effect of patient gender on short-term blood pressure variability in hemodialysis patients

    Increased blood pressure variability (BPV) is strongly associated with cardiovascular events in end-stage kidney disease patients. Male hemodialysis patients present higher cardiovascular risk compared with fe...

    Marieta P. Theodorakopoulou, Maria-Eleni Alexandrou in Journal of Human Hypertension (2023)

  7. Article

    Open Access

    Peridialytic and intradialytic blood pressure metrics are not valid estimates of 44-h ambulatory blood pressure in patients with intradialytic hypertension

    In contrast to peridialytic blood pressure (BP), intradialytic and home BP measurements are accurate metrics of ambulatory BP load in hemodialysis patients. This study assessed the agreement of peridialytic, i...

    Marieta P. Theodorakopoulou, Maria-Eleni Alexandrou in International Urology and Nephrology (2023)

  8. No Access

    Article

    Intradialytic hypertension: epidemiology and pathophysiology of a silent killer

    The term intradialytic hypertension (IDH) describes a paradoxical rise in blood pressure (BP) during or immediately after the hemodialysis session. Although it was formerly considered a phenomenon without clin...

    Fotini Iatridi, Marieta P. Theodorakopoulou, Aikaterini Papagianni in Hypertension Research (2022)

  9. No Access

    Article

    Early morning hemodynamic changes and left ventricular hypertrophy and mortality in hemodialysis patients

    An exaggeration of the early morning increase in BP, a phenomenon accompanied by a parallel rise in heart rate (HR), is a marker of high cardiovascular risk. The early morning changes in these parameters have ...

    Francesca Mallamaci, Rocco Tripepi, Claudia Torino in Journal of Nephrology (2022)

  10. No Access

    Article

    Opportunistic screening for hypertension: what does it say about the true epidemiology?

    This study aimed to assess the reliability of opportunistic screening programs in estimating the prevalence, treatment, and control rate of hypertension in the general population. Two recent epidemiological su...

    Ariadni Menti, Natasa Kalpourtzi, Magda Gavana in Journal of Human Hypertension (2022)

  11. No Access

    Article

    Meta-analysis addressing the impact of cardiovascular-acting medication on peak oxygen uptake of patients with HFpEF

    As our therapeutic armamentarium for HFpEF is insufficient, research has been focusing on the potential beneficial effect of existing pharmaceutical regimens on this specific patient population. A series of RC...

    Aristi Boulmpou, Marieta P. Theodorakopoulou in Heart Failure Reviews (2022)

  12. No Access

    Article

    Role of hypertension in kidney transplant recipients

    Cardiovascular events are one of the leading causes of mortality in kidney transplant recipients. Hypertension is the most common comorbidity accompanying chronic kidney disease, with prevalence remaining as h...

    Charalampos Loutradis, Pantelis Sarafidis in Journal of Human Hypertension (2021)

  13. Article

    Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    José M. Valdivielso, Olga Balafa, Robert Ekart, Charles J. Ferro in Drugs (2021)

  14. No Access

    Article

    Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight?

    Konstantinos Stavropoulos, Efstratios Kassimatis in Journal of Human Hypertension (2021)

  15. No Access

    Article

    Effects of intradialytic exercise on physical performance and cardiopulmonary fitness: promises that need to be confirmed

    Marieta P. Theodorakopoulou, Afroditi K. Boutou in International Urology and Nephrology (2021)

  16. No Access

    Article

    Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    Despite recent therapeutic advances, chronic kidney disease (CKD) is one of the fastest growing global causes of death. This illustrates limitations of current therapeutic approaches and, potentially, unidenti...

    José M. Valdivielso, Olga Balafa, Robert Ekart, Charles J. Ferro in Drugs (2021)

  17. No Access

    Article

    Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis

    Microvascular dysfunction is one of the hallmarks of systemic sclerosis (SSc). The presence of pulmonary-arterial-hypertension (PAH) in SSc-patients is associated with poor prognosis. This is a systematic revi...

    Marieta P. Theodorakopoulou, Ioanna Minopoulou in Rheumatology International (2021)

  18. No Access

    Article

    Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction

    Management of hypertension and albuminuria are considered among the primary goals of treatment to slow the progression of chronic kidney disease (CKD). Renin-angiotensin system (RAS) blockers, i.e., angiotensi...

    Charalampos Loutradis, Anna Price, Charles J. Ferro in Journal of Human Hypertension (2021)

  19. Article

    Open Access

    Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history

    The association of several comorbidities, including diabetes mellitus, hypertension, cardiovascular disease, heart failure and chronic kidney or liver disease, with acute kidney injury (AKI) is well establishe...

    Charalampos Loutradis, Luke Pickup, Jonathan P. Law in Biology of Sex Differences (2021)

  20. No Access

    Article

    Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis

    Cardiovascular disease is the main cause of mortality in chronic kidney disease (CKD). Endothelial dysfunction and capillary rarefaction are established cardiovascular risk factors. Nailfold video capillarosco...

    Maria Schoina, Charalampos Loutradis, Evangelos Memmos in Hypertension Research (2021)

previous disabled Page of 2